Article
NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
Neuroscience letters - 22 May 2017
Liu Hongmei, Liu Hongbo, Li Ting, Cui Jiayi, Fu Yingmei, Ren Juanjuan, Sun Xiujia, Jiang Ping, Yu Shunying, Li Chunbo
Abstract excerpt
INTRODUCTION: The homo sapiens nuclear receptor subfamily 4, group A (NR4A2) genetic variation has been implicated as a risk factor for Parkinson's disease (PD). Nevertheless, the results are inconclusive. We conducted a comprehensive systematic review and meta-analysis to quantify the impact of NR4A2 variation on the risk of PD. METHODS: All eligible case-control studies published up to June 2016 by searching...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
